Endocrinology
Advanced Endocrinology and Diabetes for Lifelong Hormonal Health.
Evidence-based care for diabetes, thyroid, adrenal, pituitary, and bone disorders.
Endocrinology at Burjeel Medical City offers comprehensive evaluation and management of hormonal and metabolic disorders, ranging from type 1 diabetes in children to adrenal tumors in adults. Our multidisciplinary collaboration with cardiology, nephrology, surgery, and nutrition ensures seamless, patient-centered care grounded in the latest research and international guidelines.
18
fellowship-trained endocrinologists9,400
patient visits annually87%
of diabetes patients reach HbA1c < 7% within 6 months1
Nationally accredited Thyroid Cancer CenterCommon Conditions & Subspecialty Clinics.
- Obesity
- Physiotherapy and occupational therapy
- Metabolic associated steatohepatitis (MASH)
- Endocrine secondary hypertension
- Syndrome of inappropriate antidiuretic hormone (SIADH)
- Hyperkalemia or hypokalemia due to endocrine causes
- MEN 1
- MEN 2A
- MEN 2B
- von Hippel–Lindau disease
- Neurofibromatosis type 1
- Insulinoma
- Gastrinoma
- Glucagonoma
- VIPoma
- Somatostatinoma
- Pancreatic neuroendocrine tumor (pNET)
- Paraganglioma
- Familial hypercholesterolemia
- Combined hyperlipidemia
- Mixed dyslipidemia
- Severe hypertriglyceridemia
- Primary ovarian insufficiency
- Amenorrhea
- Hirsutism
- Menopausal syndrome
- Male infertility due to hypogonadism
- Gynecomastia
- Abnormal uterine bleeding (AUB)
- Osteopenia
- Paget’s disease of bone
- Osteomalacia
- Chronic kidney disease–mineral bone disorder (CKD-MBD)
- Prolactinoma
- Acromegaly
- Growth hormone deficiency
- Hypopituitarism
- Non-functioning pituitary adenoma
- Diabetes insipidus
- Craniopharyngioma
- Cushing syndrome
- Addison disease
- Congenital adrenal hyperplasia
- Primary aldosteronism (Conn syndrome)
- Pheochromocytoma
- Adrenal incidentaloma
- Adrenal carcinoma
- Papillary thyroid carcinoma
- Follicular thyroid carcinoma
- Medullary thyroid carcinoma
- Anaplastic thyroid carcinoma
- Parathyroid adenoma
- Parathyroid hyperplasia
- Pelvic inflammatory disease (PID)
- Hashimoto’s thyroiditis
- Painful menstruation (dysmenorrhea)
- Graves’ disease
- Painless thyroiditis
- Postpartum thyroiditis
- Thyroid nodules
- Multinodular goiter
- Toxic adenoma
- Type 1 diabetes
- Feeding and speech therapy
- Latent autoimmune diabetes in adults (LADA)
- Gestational diabetes
- Maturity-onset diabetes of the young (MODY)
- Prediabetes
- Metabolic syndrome
Procedures & Treatments.
Genetic testing panels for MODY, MEN syndromes, familial hypercholesterolemia
24-hour urine free cortisol, catecholamines, metanephrines, and fractionated plasma metanephrines
HbA1c point-of-care testing and oral / intravenous glucose tolerance tests
DXA-based body composition analysis
Dual-energy X-ray absorptiometry (DXA)
for bone mineral density and vertebral fracture assessment
Adrenal and renal vein sampling for endocrine hypertension
Inferior petrosal sinus sampling for occult Cushing disease
Contrast-enhanced pituitary MRI and dedicated adrenal CT/MRI protocols
I-123 / I-131 SPECT/CT for thyroid cancer surveillance
Radionuclide thyroid uptake and scan (I-123 or technetium-99m)
High-resolution thyroid ultrasound with elastography and ultrasound-guided fine-needle aspiration biopsy (FNA)
Dynamic endocrine tests (ACTH stimulation
low- and high-dose dexamethasone suppression, CRH stimulation, insulin tolerance, water-deprivation, growth-hormone stimulation)
Continuous glucose monitoring (CGM) profiling and download analysis
Comprehensive metabolic and endocrine hormone panels (serum, urine, saliva)
Medical nutrition therapy and structured diabetes self-management education (DSME)
Anti-obesity pharmacotherapy (orlistat, GLP-1 / GIP-GLP-1 dual agonists, naltrexone-bupropion, phentermine-topiramate, setmelanotide)
Statins, PCSK9 inhibitors, ezetimibe, fibrates, niacin, and bempedoic acid for dyslipidemia
Testosterone, estrogen-progesterone, and selective androgen receptor modulators (SARMs) for hormone replacement therapy
Bisphosphonates, denosumab, teriparatide, romosozumab, and selective estrogen receptor modulators (SERMs) for osteoporosis
Somatostatin analogs, growth-hormone receptor antagonists, and PEG-visomant for acromegaly
Dopamine agonists (cabergoline, bromocriptine) for prolactinomas
Mineralocorticoid receptor antagonists
or targeted therapy (e.g., eplerenone) for primary aldosteronism
Glucocorticoid and mineralocorticoid replacement for adrenal insufficiency
Radioactive iodine ablation for hyperthyroidism and differentiated thyroid cancer
Antithyroid medications (methimazole, propylthiouracil) with beta-blocker preparation for symptom control
Thyroid hormone replacement (levothyroxine, liothyronine) and combination therapy when indicated
Sodium-glucose cotransporter 2 (SGLT2) inhibitors for cardiorenal protection
Injectable antihyperglycemic agents (GLP-1 receptor agonists, dual-incretin agonists, amylin analogs, once-weekly insulin)
Oral antihyperglycemic agents (metformin, sulfonylureas, thiazolidinediones, DPP-4 inhibitors)
Intensive insulin therapy (multiple daily injections) and continuous subcutaneous insulin infusion (CSII) with hybrid closed-loop systems
Intra-operative neural monitoring (IONM) and nerve integrity assessment during thyroid and parathyroid surgery (with ENT / Head & Neck Surgery)
Bariatric surgical and endoscopic procedures (sleeve gastrectomy, Roux-en-Y gastric bypass, endoscopic sleeve gastroplasty) as part of the Medical Weight Management pathway
Endoscopic transsphenoidal pituitary tumor resection and stereotactic radiosurgery (Gamma Knife / CyberKnife) for residual disease (with Neurosurgery)
Image-guided percutaneous vertebral augmentation for fracture stabilization in severe osteoporosis
Laparoscopic and retroperitoneoscopic adrenalectomy for functional/malignant adrenal lesions
Image-guided percutaneous vertebral augmentation for fracture stabilization in severe osteoporosis
Laparoscopic and retroperitoneoscopic adrenalectomy for functional/malignant adrenal lesions
Selective parathyroid venous sampling and minimally invasive parathyroidectomy (with Endocrine Surgery)
Microwave or radiofrequency ablation of adrenal and pancreatic neuroendocrine tumors (in collaboration with Interventional Radiology)
Ultrasound-guided ethanol and radiofrequency ablation (RFA) of benign thyroid nodules and cysts
Care Pathway & Coordination.
1
Initial Consultation & Baseline Testing
Complete history, exam, labs, and imaging reviewed in a single visit.
2
Integrated Case Review
Endocrinologist, dietitian, diabetes educator, and pharmacist refine a personalized plan.
3
Therapy Initiation & Digital Monitoring
Medication optimization, CGM enrollment, and lifestyle coaching via patient portal.
4
Follow-up & Long-Term Surveillance
Ninety-day outcome check, annual screening schedule, and rapid return if parameters drift.
Technology & Facilities.
Hybrid Closed-Loop Insulin Pumps
Automated insulin delivery with real-time glucose feedback.
I-123 SPECT/CT Thyroid Imaging
Detects residual tissue with 97% sensitivity.
DEXA-Based Body Composition Lab
Precise fat-mass versus lean-mass analysis in six minutes.
On-Site Endocrine Laboratory
Comprehensive hormone assays with 24-hour turnaround.
